Posted on November 5, 2018
TORONTO, Nov. 5, 2018 /CNW/ - Natura Naturals Holdings Inc. ("Natura Naturals") has successfully closed $4.4 million of convertible debenture financing (the "Debentures"). The Debentures have a coupon of 8% and a Maturity Date of October 15, 2019 and are convertible into the common shares of Natura Naturals.
The proceeds will be used for general working capital purposes and to fund the preliminary construction capex of Natura Naturals' Phase 2 expansion, which will add an additional 463,000 square feet of flowering area to the Leamington facility.
About Natura Naturals Holdings Inc.
Based in Leamington, Ontario, Natura Naturals Holdings Inc. is a licensed cultivator of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations ("ACMPR"). The Company's cultivation facility is capable of producing plants in a 662,000+ square foot greenhouse facility under optimal growing conditions. Natura Naturals grows high-quality hydroponic cannabis which can be used for various medical and recreational applications. Natura Naturals has an extensive genetics library and continues to develop innovative products for the Canadian and International marketplace.
SOURCE Natura Naturals
For further information: For media inquiries only please contact: Alexander C. Logie, SVP Business Development, Natura Naturals Inc., (647) 216-8997, firstname.lastname@example.org